GSK: story ‘unfair'

Share this article:
GlaxoSmithKline's director of CME took exception with a Wall Street Journal report on GSK-funded med ed.

The December 2006 article asserts that GSK paid for a series of lectures by doctors who favor universal screening and treatment of pregnant women for genital herpes (MM&M, January 2007), two contentious issues.

“Your article implies that the industry uses [CME] as a means to promote product; this unfairly taints the value that quality CME brings to healthcare professionals and to the patients,” wrote Bryan King, PharmD, director, GSK Center for Medical Education, in a letter to the editor.
GSK's Valtrex is not approved to prevent neonatal herpes in pregnant women.

Share this article:

Email Newsletters

More in News

Star Group merges with Vox Medica, Calcium NYC

Star Group merges with Vox Medica, Calcium NYC

The newly formed group will be known as Calcium with Steve Michaelson, formerly of Rosetta Wishbone, at the helm.

Survey finds pay doesn't make doctors happy

Survey finds pay doesn't make doctors happy

Medscape's survey of over 24,000 physicians found that a paycheck is not necessarily linked to a physician's professional satisfaction.

CDC sees declines in some diabetes complications

CDC sees declines in some diabetes complications

Centers for Disease Control data shows that diabetes complications including heart attack and amputation fell in the twenty years between 1990 and 2010. The bad news: the number of diagnosed ...